Notice of Availability for Licensing-NIST's Patented Microfluidic Apparatus and Method To Control Liposome Formation, 78792-78793 [2016-26995]
Download as PDF
78792
Federal Register / Vol. 81, No. 217 / Wednesday, November 9, 2016 / Notices
requirements will be effective upon
publication of the final results for
shipments of the subject merchandise
from Vietnam entered, or withdrawn
from warehouse, for consumption on or
after the publication date, as provided
by sections 751(a)(2)(C) of the Act: (1)
For the companies listed above, which
have a separate rate, the cash deposit
rate will be that established in the final
results of this review (except, if the rate
is zero or de minimis, then zero cash
deposit will be required); (2) for
previously investigated or reviewed
Vietnam and non-Vietnam exporters not
listed above that received a separate rate
in a prior segment of this proceeding,
the cash deposit rate will continue to be
the existing exporter-specific rate; (3) for
all Vietnam exporters of subject
merchandise that have not been found
to be entitled to a separate rate, the cash
deposit rate will be the existing rate for
the Vietnam-Wide entity of 25.76
percent; and (4) for all non-Vietnam
exporters of subject merchandise which
have not received their own rate, the
cash deposit rate will be the rate
applicable to the Vietnam exporter that
supplied that non-Vietnam exporter.
These deposit requirements, when
imposed, shall remain in effect until
further notice.
Notification to Importers
This notice also serves as a
preliminary reminder to importers of
their responsibility under 19 CFR
351.402(f)(2) to file a certificate
regarding the reimbursement of
antidumping duties prior to liquidation
of the relevant entries during this
review period. Failure to comply with
this requirement could result in the
Department’s presumption that
reimbursement of antidumping duties
occurred and the subsequent assessment
of double antidumping duties.
This determination is issued and
published in accordance with sections
751(a)(1) and 777(i)(1) of the Act and 19
CFR 351.221(b)(4).
Dated: October 31, 2016.
Paul Piquado,
Assistant Secretary for Enforcement and
Compliance.
sradovich on DSK3GMQ082PROD with NOTICES
Appendix I
List of Topics Discussed in the Preliminary
Decision Memorandum
I. Summary
II. Background
III. Scope of the Order
IV. Discussion of the Methodology
a. Respondent Selection
b. Preliminary Determination of No
Shipments
c. Non-Market Economy Country
d. Separate Rates
VerDate Sep<11>2014
16:29 Nov 08, 2016
Jkt 241001
e. The Vietnam-Wide Entity
f. Separate Rate for Eligible, Non-Examined
Respondents
V. Recommendation
Appendix II
Companies Subject To Review Determined
To Be Part of the Vietnam-Wide Entity
1. Amanda Foods (Vietnam) Ltd. Ngoc Tri
Seafood Company (Amanda’s affiliate)
2. Amanda Seafood Co., Ltd.
3. An Giang Coffee JSC
4. Anvifish Joint Stock Co.
5. Asia Food Stuffs Import Export Co., Ltd.
6. Binh Thuan Import—Export Joint Stock
Company (THAIMEX)
7. Binh An Seafood Joint Stock Company
8. B.O.P. Limited Co.
9. C.P. Vietnam Corporation, aka
C.P. Vietnam Corporation (‘‘C.P.
Vietnam’’), aka
C.P. Vietnam Livestock Company Limited,
aka
C.P. Vietnam Livestock Corporation
10. Can Tho Agricultural and Animal
Product Import Export Company
(‘‘CATACO’’), aka
Can Tho Agricultural and Animal Products
Import Export Company (‘‘CATACO’’),
aka
Can Tho Agricultural and Animal Products
Imex Company, aka
Can Tho Agricultural Products
11. Can Tho Import Export Seafood Joint
Stock Company (CASEAMEX)
12. Cautre Export Goods Processing Joint
Stock Company
13. Coastal Fisheries Development
Corporation (‘‘COFIDEC’’)
14. Danang Seaproducts Import-Export
Corporation (‘‘Seaprodex Danang’’) (and
its affiliates), aka
Danang Seaproducts Import Export
Corporation (and its affiliate, Tho Quang
Seafood Processing and Export
Company) (collectively, ‘‘Seaprodex
Danang’’)), aka
Danang Seaproducts Import Export
Corporation (‘‘Seaprodex Danang’’), aka
Seaprodex Danang, aka
Tho Quang Co, aka
Tho Quang Seafood Processing and Export
Company, aka
Frozen Seafoods Factory No. 32 (Tho
Quang Seafood Processing and Export
Company)
15. Duy Dai Corporation
16. D & N Foods Processing (Danang
Company Ltd.)
17. Gallant Ocean (Quang Ngai) Co., Ltd.
18. Gn Foods
19. Hai Thanh Food Company Ltd.
20. Hai Vuong Co., Ltd.
21. Han An Trading Service Co., Ltd.
22. Hoang Hai Company Ltd.
23. Hua Heong Food Industries Vietnam Co.
Ltd.
24. Huynh Huong Seafood Processing
(Huynh Houng Trading and Import
Export Joint Stock Company)
25. Kien Long Seafoods Co. Ltd.
26. Khanh Loi Seafood Factory
27. Long Toan Frozen Aquatic Products Joint
Stock Company
28. Luan Vo Fishery Co., Ltd.
29. Minh Chau Imp. Exp. Seafood Processing
PO 00000
Frm 00021
Fmt 4703
Sfmt 4703
Co., Ltd.
30. Mp Consol Co., Ltd.
31. New Wind Seafood Co., Ltd.
32. Ngoc Chau Co., Ltd. and/or Ngoc Chau
Seafood Processing Company
33. Ngoc Sinh, aka
Ngoc Sinh Fisheries, aka
Ngoc Sinh Private Enterprises, aka
Ngoc Sinh Seafoods, aka
Ngoc Sinh Seafood Processing Company,
aka
Ngoc Sinh Seafood Trading & Processing
Enterprise
34. Nhat Duc Co., Ltd. (‘‘Nhat Duc’’), aka
Nhat Duc Co., Ltd., aka
Nhat Duc Co. Ltd.
35. Phu Cuong Jostoco Seafood Corporation,
aka
Phu Cuong Jostoco Corp.
36. Quoc Ai Seafood Processing Import
Export Co., Ltd.
37. S.R.V. Freight Services Co., Ltd.
38. Saigon Food Joint Stock Company
39. Sustainable Seafood
40. Tan Thanh Loi Frozen Food Co., Ltd.
41. Tan Phong Phu Seafood Co., Ltd., aka
Tan Phong Phu Seafood Company Ltd.
(‘‘TPP Co., Ltd.’’), aka
Tan Phong Phu Seafood Co. Ltd. (‘‘TPP Co.,
Ltd.’’)
42. Thanh Doan Seaproducts Import & Export
Processing Joint-Stock Company
(THADIMEXCO)
43. Thanh Hung Frozen Seafood Processing
Import Export Co., Ltd.
44. Thanh Tri Seafood Processing Co. Ltd.
45. Thinh Hung Co., Ltd.
46. Trang Khan Seafood Co., Ltd.
47. Tien Tien Garment Joint Stock Company
48. Tithi Co., Ltd.
49. Viet Cuong Seafood Processing Import
Export Joint-Stock Company
50. Vietnam Northern Viking Technologies
Co. Ltd.
51. Vinatex Danang
52. Vinh Loi Import Export Company
(‘‘VIMEX’’), aka
Vinh Loi Import Export Company
(‘‘Vimexco’’)
53. Xi Nghiep Che Bien Thuy Sue San Xuat
Kau Cantho
[FR Doc. 2016–27071 Filed 11–8–16; 8:45 am]
BILLING CODE 3510–DS–P
DEPARTMENT OF COMMERCE
National Institute of Standards and
Technology
Notice of Availability for Licensing—
NIST’s Patented Microfluidic
Apparatus and Method To Control
Liposome Formation
National Institute of Standards
and Technology.
ACTION: Notice.
AGENCY:
The National Institute of
Standards and Technology (NIST), an
agency of the United States Department
of Commerce, owns two patents related
to controlled liposome formation using
microfluidic channels: U.S. Patent
SUMMARY:
E:\FR\FM\09NON1.SGM
09NON1
sradovich on DSK3GMQ082PROD with NOTICES
Federal Register / Vol. 81, No. 217 / Wednesday, November 9, 2016 / Notices
9,198,645, titled ‘‘Controlled Vesicle
Self-Assembly in Continuous Two
Phase Flow Microfluidic Channels’’
(NIST Docket 04–003); and U.S. Patent
8,715,591, title ‘‘Microfluidic Apparatus
to Control Liposome Formation’’ (NIST
Docket 09–017). Further details about
these patents are provided in the
SUPPLEMENTARY INFORMATION section,
below.
ADDRESSES: For further information
about these patented inventions or other
licensing and partnership opportunities,
please contact Honeyeh Zube, CRADA
and License Officer, National Institute
of Standards and Technology’s
Technology Partnerships Office, by mail
to 100 Bureau Drive, Mail Stop 2200,
Gaithersburg, Maryland 20899, by
electronic mail to honeyeh.zube@
nist.gov, or by telephone at (301) 975–
2209.
SUPPLEMENTARY INFORMATION: NIST’s
Patent 9,198,645, titled ‘‘Controlled
Vesicle Self-Assembly in Continuous
Two Phase Flow Microfluidic
Channels’’ (NIST Docket 04–003) claims
novel methods for the formation of
liposomes that encapsulate reagents in a
continuous two-phase flow microfluidic
network with precision control of size,
for example, from 100 nm to 300 nm, by
manipulation of liquid flow rates are
described. By creating a solvent-aqueous
interfacial region in a microfluidic
format that is homogenous and
controllable on the length scale of a
liposome, fine control of liposome size
and polydispersity can be achieved.
NIST’s Patent 8,715,591, title
‘‘Microfluidic Apparatus to Control
Liposome Formation,’’ (NIST Docket
09–017) is available for license and
claims the apparatus and method of
using a microfluidic device that controls
the amount of delivery compound
incorporated in a liposome on a
nanometer size scale using laminar flow
and miscible fluids, thereby increasing
loading efficiency. The patent was filed
on Apr. 19, 2010 and was issued on May
6, 2014. The invention was first
published in Jahn, et al., Microfluidic
Directed Formation of Liposomes of
Controlled Size, American Chemical
Society Langmuir, 23 (11) pp 6289–
6293. 2007.
The liposomes formed by the selfassembly process are characterized
using asymmetric flow field-flow
fractionation combined with quasielastic light scattering and multiangle
laser-light scattering. The vesicle size
and size distribution are tunable over a
mean diameter from 50 to 150 nm by
adjusting the ratio of the alcohol-toaqueous volumetric flow rate. Liposome
formation depends more strongly on the
VerDate Sep<11>2014
16:29 Nov 08, 2016
Jkt 241001
focused alcohol stream width and its
diffusive mixing with the aqueous
stream than on the sheer forces at the
solvent-buffer interface. The inventions
have application in drug delivery, gene
therapy, and potential application for
on-demand liposome-mediated delivery
of point-of-care therapeutics. The
inventions can obviate the need for
post-processing in drug manufacturing.
NIST is authorized to license its rights
in these inventions to organizations on
a non-exclusive or exclusive basis for
specified fields of use. The rights to
these patents are available for exclusive
or non-exclusive licensing by the
authority granted to the NIST under 35
U.S.C. 209 and 37 CFR 404. NIST
researchers are interested in potential
collaborations with licensees to bring
this invention to practical application
and to promote innovation, enhance
economic security and improve quality
of life.
Kevin Kimball,
Chief of Staff.
[FR Doc. 2016–26995 Filed 11–8–16; 8:45 am]
BILLING CODE 3510–13–P
DEPARTMENT OF COMMERCE
National Oceanic and Atmospheric
Administration
Submission for OMB Review;
Comment Request
The Department of Commerce will
submit to the Office of Management and
Budget (OMB) for clearance the
following proposal for collection of
information under the provisions of the
Paperwork Reduction Act (44 U.S.C.
Chapter 35).
Agency: National Oceanic and
Atmospheric Administration (NOAA).
Title: Implementation of Vessel Speed
Restrictions to Reduce the Threat of
Ship Collisions with North Atlantic
Right Whales.
OMB Control Number: 0648–0580.
Form Number(s): None.
Type of Request: Regular (extension of
a currently approved information
collection).
Number of Respondents: 3,047.
Average Hours per Response: 5
minutes.
Burden Hours: 254.
Needs and Uses: This request is for an
extension of a current information
collection. On October 10, 2008, NMFS
published a final rule promulgated
under the Endangered Species Act
implementing speed restrictions to
reduce the incidence and severity of
ship collisions with North Atlantic right
whales (73 FR 60173). That final rule
PO 00000
Frm 00022
Fmt 4703
Sfmt 4703
78793
contained a collection-of-information
requirement subject to the Paperwork
Reduction act (PRA). Specifically, 50
CFR 224.105(c) requires a logbook entry
to document that a deviation from the
10-knot speed limit was necessary for
safe maneuverability under certain
conditions.
In certain sea and weather conditions,
a large ship may lose maneuverability at
slow speeds. Therefore, under such
conditions a ship, at the captain’s
discretion, may opt not to abide by the
speed restrictions. If she/he chooses this
option, she/he is required to make an
entry into the ship’s log, providing such
information as: the reasons for the
deviation, the speed at which the vessel
is operated, the area, and the time and
duration of such deviation.
Affected Public: Business or other forprofit organizations.
Frequency: On occasion.
Respondent’s Obligation: Mandatory.
This information collection request
may be viewed at reginfo.gov. Follow
the instructions to view Department of
Commerce collections currently under
review by OMB.
Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to OIRA_Submission@
omb.eop.gov or fax to (202) 395–5806.
Dated: November 3, 2016.
Sarah Brabson,
NOAA PRA Clearance Officer.
[FR Doc. 2016–27012 Filed 11–8–16; 8:45 am]
BILLING CODE 3510–22–P
DEPARTMENT OF DEFENSE
Office of the Secretary
[Docket ID: DOD–2016–OS–0062]
Submission for OMB Review;
Comment Request
ACTION:
Notice.
The Department of Defense
has submitted to OMB for clearance, the
following proposal for collection of
information under the provisions of the
Paperwork Reduction Act.
DATES: Consideration will be given to all
comments received by December 9,
2016.
FOR FURTHER INFORMATION CONTACT: Fred
Licari, 571–372–0493.
SUPPLEMENTARY INFORMATION:
Title, Associated Form and OMB
Number: Synchronized Predeployment
and Operational Tracker Enterprise
Suite (SPOT–ES); OMB Control Number
0704–0460.
SUMMARY:
E:\FR\FM\09NON1.SGM
09NON1
Agencies
[Federal Register Volume 81, Number 217 (Wednesday, November 9, 2016)]
[Notices]
[Pages 78792-78793]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-26995]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
National Institute of Standards and Technology
Notice of Availability for Licensing--NIST's Patented
Microfluidic Apparatus and Method To Control Liposome Formation
AGENCY: National Institute of Standards and Technology.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The National Institute of Standards and Technology (NIST), an
agency of the United States Department of Commerce, owns two patents
related to controlled liposome formation using microfluidic channels:
U.S. Patent
[[Page 78793]]
9,198,645, titled ``Controlled Vesicle Self-Assembly in Continuous Two
Phase Flow Microfluidic Channels'' (NIST Docket 04-003); and U.S.
Patent 8,715,591, title ``Microfluidic Apparatus to Control Liposome
Formation'' (NIST Docket 09-017). Further details about these patents
are provided in the SUPPLEMENTARY INFORMATION section, below.
ADDRESSES: For further information about these patented inventions or
other licensing and partnership opportunities, please contact Honeyeh
Zube, CRADA and License Officer, National Institute of Standards and
Technology's Technology Partnerships Office, by mail to 100 Bureau
Drive, Mail Stop 2200, Gaithersburg, Maryland 20899, by electronic mail
to honeyeh.zube@nist.gov, or by telephone at (301) 975-2209.
SUPPLEMENTARY INFORMATION: NIST's Patent 9,198,645, titled ``Controlled
Vesicle Self-Assembly in Continuous Two Phase Flow Microfluidic
Channels'' (NIST Docket 04-003) claims novel methods for the formation
of liposomes that encapsulate reagents in a continuous two-phase flow
microfluidic network with precision control of size, for example, from
100 nm to 300 nm, by manipulation of liquid flow rates are described.
By creating a solvent-aqueous interfacial region in a microfluidic
format that is homogenous and controllable on the length scale of a
liposome, fine control of liposome size and polydispersity can be
achieved.
NIST's Patent 8,715,591, title ``Microfluidic Apparatus to Control
Liposome Formation,'' (NIST Docket 09-017) is available for license and
claims the apparatus and method of using a microfluidic device that
controls the amount of delivery compound incorporated in a liposome on
a nanometer size scale using laminar flow and miscible fluids, thereby
increasing loading efficiency. The patent was filed on Apr. 19, 2010
and was issued on May 6, 2014. The invention was first published in
Jahn, et al., Microfluidic Directed Formation of Liposomes of
Controlled Size, American Chemical Society Langmuir, 23 (11) pp 6289-
6293. 2007.
The liposomes formed by the self-assembly process are characterized
using asymmetric flow field-flow fractionation combined with quasi-
elastic light scattering and multiangle laser-light scattering. The
vesicle size and size distribution are tunable over a mean diameter
from 50 to 150 nm by adjusting the ratio of the alcohol-to-aqueous
volumetric flow rate. Liposome formation depends more strongly on the
focused alcohol stream width and its diffusive mixing with the aqueous
stream than on the sheer forces at the solvent-buffer interface. The
inventions have application in drug delivery, gene therapy, and
potential application for on-demand liposome-mediated delivery of
point-of-care therapeutics. The inventions can obviate the need for
post-processing in drug manufacturing.
NIST is authorized to license its rights in these inventions to
organizations on a non-exclusive or exclusive basis for specified
fields of use. The rights to these patents are available for exclusive
or non-exclusive licensing by the authority granted to the NIST under
35 U.S.C. 209 and 37 CFR 404. NIST researchers are interested in
potential collaborations with licensees to bring this invention to
practical application and to promote innovation, enhance economic
security and improve quality of life.
Kevin Kimball,
Chief of Staff.
[FR Doc. 2016-26995 Filed 11-8-16; 8:45 am]
BILLING CODE 3510-13-P